Trial intelligence / Profile preview

Effect of betahistine and dimenhydrinate in benign paroxysmal positional vertigo

IRCT201506231138N20Phase 2Completed

Sponsor
Guilan University of Medical Sciences
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of betahistine and dimenhydrinate in benign paroxysmal positional vertigo (BPPV) (2 arms), sponsored by Guilan University of Medical Sciences. Started Jul 2015; status: completed.

02

Drugs

betahistinedimenhydrinate
03

Conditions

benign paroxysmal positional vertigo (BPPV)

Beyond the preview

Go deeper on IRCT201506231138N20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201506231138N20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call